Blog

Veli Bakalov: My first investigator-initiated clinical trial is now open for enrollment

Veli Bakalov/X

Dec 9, 2024, 14:35

Veli Bakalov: My first investigator-initiated clinical trial is now open for enrollment

Veli Bakalov, Oncologist at MD Anderson Cancer center at Cooper University Health Care and Author of HemeOncBuddy app, shared a post on X:

“Announcement.

My first investigator-initiated clinical trial, INSPIRE-CRT, is now open for enrollment at MD Anderson Cancer Center at Cooper University Health Care.

We are studying if incentive spirometry can reduce pneumonitis rates, severity, and hospitalizations in lung cancer patients undergoing chemoradiation and maintenance treatment (ICI or TKI).

Your support matters.

If interested in opening this trial at your site, please DM for details.

Together, let’s improve outcomes and quality of life for lung cancer patients.”

Veli Bakalov

For more updates, follow OncoDaily.

cancer Cancer Center chemoradiation Cooper University Health Care health health care INSPIRE-CRT Lung cancer lung cancer patients MD Anderson Cancer Center OncoDaily Oncology patients pneumonitis spirometry Veli Bakalov

New Paper Alert: Hepatocellular Carcinoma - Stereotactic Body Radiotherapy vs Sorafenib Alone in the NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial - JAMA Oncology

Monica Bertagnolli: 2024 Science Highlights from the NIH Director’s Blog

365 Days of OncoDaily: Ending 2024 Strong

Aladina Foundation was Honored with the Yvonne Humanitarian Award by OncoDaily

Rod Stewart and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage